Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN1 | Q05586 | 4/20 | 0.35 |
| ▸ | GRIN2A | Q12879 | 4/20 | 0.35 |
| ▸ | GRIN2D | O15399 | 3/20 | 0.35 |
| ▸ | GRIN3B | O60391 | 3/20 | 0.35 |
| ▸ | GRIN2B | Q13224 | 3/20 | 0.35 |
| ▸ | GRIN2C | Q14957 | 3/20 | 0.35 |
| ▸ | GRIN3A | Q8TCU5 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 2/20 | 0.35 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.35 |
| ▸ | ESR1 | P03372 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.35 |
| ▸ | MTOR | P42345 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9115343 | 0.69 | LMNA (0.31) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL8940989 | 0.69 | GRIN1 (0.36) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL2545728 | 0.69 | LMNA (0.31) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL11699962 | 0.69 | GRIN1 (0.34) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL28016129 | 0.67 | PKM (0.31) | — | |
| SCHEMBL733849 | 0.65 | GRIN1 (0.48) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL3190483 | 0.65 | GRIN1 (0.48) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| Bromide SCHEMBL4732099 | 0.62 | GRIN1 (0.46) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL812216 | 0.62 | GRIN1 (0.68) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B | |
| SCHEMBL11405480 | 0.62 | PKM (0.44) | GRIN1GRIN2AGRIN2DGRIN3BGRIN2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112684082-A | Method for identifying crude oil type | 中国石油化工股份有限公司 | 2021-04-20 | — | — | CN | claimed |
| CN-117007725-B | Column chromatography sample online concentration device, method and application | 大庆油田有限责任公司 | 2025-02-21 | — | — | CN | disclosed |
| CN-117007725-A | Column chromatography sample online concentration device, method and application | 大庆油田有限责任公司 | 2023-11-07 | — | — | CN | disclosed |
| CN-112684082-A | Method for identifying crude oil type | 中国石油化工股份有限公司 | 2021-04-20 | — | — | CN | disclosed |
| EP-2331495-B1 | PROCESS FOR MANUFACTURING ADAMANTANE DERIVATIVES WITH HIGH YIELD | MERZ PHARMA GMBH & CO KGAA (DE) | 2016-01-27 | — | — | EP | disclosed |
| US-8796491-B2 | Process for manufacturing adamantane derivatives with high yield | MERZ PHARMA GMBH & CO. KGAA (DE) | 2014-08-05 | — | — | US | disclosed |
| US-20110263900-A1 | PROCESS FOR MANUFACTURING ADAMANTANE DERVATIVES WITH HIGH YIELD | MERZ PHARMA GMBH & CO. KGAA (DE) | 2011-10-27 | — | — | US | disclosed |
| EP-0715612-A4 | — | — | 1996-07-03 | — | — | EP | disclosed |
| EP-0715612-A1 | ISOLATION OF HIGH PURITY DIAMONDOID, FRACTIONS AND COMPONENTS | MOBIL OIL CORPORATION (US) | 1996-06-12 | — | — | EP | disclosed |
| WO-1995011472-A1 | FIBER OPTIC CABLE AND VISCOUS FILLER MATERIAL | MOBIL OIL CORPORATION (US) | 1995-04-27 | — | — | WO | disclosed |
| WO-1995006019-A1 | ISOLATION OF HIGH PURITY DIAMONDOID, FRACTIONS AND COMPONENTS | MOBIL OIL CORPORATION (US) | 1995-03-02 | — | — | WO | disclosed |
| WO-1995001319-A1 | OXIDATIVE COUPLING OF DIAMONDOIDS AND AROMATICS | MOBIL OIL CORPORATION (US) | 1995-01-12 | — | — | WO | disclosed |
| WO-1994029244-A1 | LUBRICANT COMPOSITION AND METHOD FOR INCREASING DIAMONDOID INCORPORATION IN POLYALPHAOLEFIN-CONTAINING LUBRICANT | MOBIL OIL CORPORATION (US) | 1994-12-22 | — | — | WO | disclosed |
| US-4043927-A | Friction or tractive drive containing ethers of adamantanes | SUN VENTURES, INC. (US) | 1977-08-23 | — | — | US | disclosed |
| US-4008251-A | TRACTION FLUID ADDITIVES | SUN OIL COMPANY, (SUN RESEARCH AND DEVELOPMENT CO.) | 1977-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110263900-A1 | PROCESS FOR MANUFACTURING ADAMANTANE DERVATIVES WITH HIGH YIELD | BACE1, BACE2, APP | GRIN1 958/4885GRIN2A 870/4885GRIN2D 1299/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.